Home / Inspections / 1023799

FDA Inspection 1023799 — Texas Oncology, P.A. - South Texas Cancer Center

Texas Oncology, P.A. - South Texas Cancer Center — FEI 1000149813

The FDA completed an inspection of Texas Oncology, P.A. - South Texas Cancer Center on August 8, 2017 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 8, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mcallen, TX (United States)

Facility

Other inspections at this facility

  • 1253544 (NAI Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1095924 (NAI Mon Jun 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 932130 (NAI Fri Jun 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 808138 (NAI Wed Oct 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694558 (NAI Wed Oct 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources